Advertisement

Topics

US fraud trial underway for pharma bad boy Shkreli

23:11 EDT 28 Jun 2017 | Medical Xpress

The US securities fraud trial of Martin Shkreli, a former pharmaceutical executive who gained notoriety for jacking up the price of an HIV drug by 5,000 percent, got underway on Wednesday after being delayed over difficulties in finding impartial jurors.

Original Article: US fraud trial underway for pharma bad boy Shkreli

NEXT ARTICLE

More From BioPortfolio on "US fraud trial underway for pharma bad boy Shkreli"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...